Arkolith/Insider Trading/SMMT/Form 4

Zanganeh Mahkam

Chief Executive Officer, DirectorSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Mar 27, 2024
Net Buying
Open-Market Buys
$411K
Open-Market Sells
$0
Net Open-Market Flow
$411K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 27, 2024Buy(P)20K$3.71$74K50K
Mar 27, 2024Buy(P)34K$3.72$128K24.9M
Mar 27, 2024Buy(P)26K$3.72$97K521K
Mar 26, 2024Buy(P)30K$3.75$113K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599298-24-000047) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML